Latest news
Natural compound may help boost vaccine responses
A team of researchers has found that the naturally occurring compound spermidine can help boost vaccine response in older adults by reducing molecular markers of immune system ageing.
Long-term hepatitis control efforts dramatically reduce HBV and HCV burden in Japan
Researchers have estimated that the number of HBV infections in Japan could decline gradually down to around 200,000 cases by 2050, down from an estimate of 923,000 to 940,000 cases in 2020. HCV is estimated to decline to less than 20,000 cases.
Landmark study reveals ‘megacluster’ of bacterial genes behind arsenal of potent antibiotics
A newly discovered “megacluster” of genes in Streptomyces bacteria produces four new natural product antibiotics that work together to stop rival bacteria.
Biofilm “scaffolds” protect bacterium responsible for food poisoning from antibiotics
Bacillus cereus, which is responsible for human infections and food poisoning, builds organized communities that act as a ‘shield’ against antibiotics, a new study reveals.
Free webinar: The mystery of the missing microbes - and the answers that can be found in the Amazon
An intriguing free webinar this July will explore what happens when key members of the human gut microbiome are lost, and what we can learn from populations where this loss has not occurred.
Healthy infant microbiomes appear to protect against malaria
A small preliminary study shows that 6-week-old infants with healthy gut microbiomes are less likely to contract malaria in their first year of life, suggesting the intriguing possibility that treatments such as probiotics could be protective against malaria.
Natural compound may help boost vaccine responses
A team of researchers has found that the naturally occurring compound spermidine can help boost vaccine response in older adults by reducing molecular markers of immune system ageing.
Long-term hepatitis control efforts dramatically reduce HBV and HCV burden in Japan
Researchers have estimated that the number of HBV infections in Japan could decline gradually down to around 200,000 cases by 2050, down from an estimate of 923,000 to 940,000 cases in 2020. HCV is estimated to decline to less than 20,000 cases.
Landmark study reveals ‘megacluster’ of bacterial genes behind arsenal of potent antibiotics
A newly discovered “megacluster” of genes in Streptomyces bacteria produces four new natural product antibiotics that work together to stop rival bacteria.
Bruke showcases expanding Microbiology & Infection Diagnostics portfolio at ASM Microbe 2026
At ASM Microbe 2026, Bruker Corporation’s Microbiology & Infection Diagnostics (BMID) division demonstrated its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.
Andelyn Biosciences launches LVV Curator® Platform
Andelyn Biosciences has announced the launch of its LVV Curator® Platform, a standardized lentiviral vector (LVV) manufacturing solution built on the same proven modular approach that supports clinical and commercial adeno-associated virus (AAV) programs.
Modular Clean Air strengthens position as part of Total Clean AIr
Modular Clean Air (MCA) is now wholly owned by Total Clean Air (TCA), marking the next phase in its development following its successful launch as a joint venture in 2025.
Algae microbots take aim at bladder cancer
Tiny algae-based robots guided by magnets could improve bladder cancer treatment by boosting delivery of chemotherapy drugs into tumours. Tracked using real-time imaging, the miniature robots help drugs penetrate deep into tumour tissue while limiting damage to healthy cells.
Biochar-coated catalyst turns wet microalgae into cleaner fuel-building chemicals
Turning microalgae into usable liquid fuels remains difficult because algae-derived bio-oil often contains high levels of oxygen and nitrogen compounds. A new study reports a promising strategy to address this challenge.
Microscope breakthrough will open unprecedented view into cells
In a landmark achievement in biological imaging, researchers have announced the successful demonstration of the laser phase plate, a novel device that dramatically improves the contrast of images produced by cryo-electron microscopes, opening up an entirely new view of human biology.
Free webinar: The mystery of the missing microbes - and the answers that can be found in the Amazon
An intriguing free webinar this July will explore what happens when key members of the human gut microbiome are lost, and what we can learn from populations where this loss has not occurred.
International Photodynamic Association highlights expansion of photodynamic therapy
The International Photodynamic Association (IPA) convened global leaders in photodynamic therapy (PDT) at the 8th Photodynamic Day, highlighting the continued development of PDT in Türkiye and its growing clinical relevance internationally.
Share your story: Neurodivergent STEM professionals invited to take part in video project
Applied Microbiology International (AMI) is inviting researchers, students and professionals across the STEM community to take part in a new video series exploring the experiences of neurodivergent people working in science, technology, engineering and mathematics.